Section 1
Key takeaways
• Most B2B deals don't die to a competitor or to price, they die to indecision. The JOLT Effect study found 40%–60% of deals are lost to customer indecision , and Challenger found 38% of purchase attempts end in "no decision" . • An un-quantified problem has no dollar sign, so the only number in the room is your price, which is why the buyer shops you line by line instead of weighing the cost of not fixing it. • Quantify the bleed and you stop competing with other vendors and start competing with the buyer's own inaction, which has no salespeople, never gets on a comparison grid, and never lowers its price. • The Bleed Number is a discovery method, not a pitch: get volume, value, frequency, and failure rate from the buyer's own mouth, add it up out loud, and make them confirm the monthly loss. • A number survives the room of 11-plus stakeholders that your champion has to re-sell to without you; a feature list does not.
Section 2
The misdiagnosis: you think you're losing to competitors. You're losing to nothing.
Here's the uncomfortable data. When B2B deals die, they overwhelmingly don't die because a rival won. They die because nobody decided anything. The JOLT Effect research from Matthew Dixon and Ted McKenna, a study of recorded sales calls, found that 40% to 60% of deals are lost to customer indecision, not to a competitor and not to price . An independent HBR analysis landed in the exact same band: 40% to 60% of B2B deals end in no decision . And Challenger's B2B buying study put a clean number on the dominant failure mode: 38% of purchase attempts end in "no decision", buyers who start a process, take the calls, request the proposal, and then simply never commit . Sit with that. The single most common outcome of a sales process isn't a yes and isn't a no. It's a shrug. The competitor that's eating your pipeline is the status quo, the buyer continuing to do exactly what they were doing before you showed up, because the cost of changing felt more real than the cost of staying put. Now the part that should change how you run every discovery call. Of those no-decision losses, JOLT found that 56% stem from active indecision, fear of messing up, of buying the wrong thing, of being the person who championed a flop, while only 44% come from a genuine preference for the status quo . Read that again. The majority of buyers who ghost you wanted to move. They weren't sitting on their hands because they loved their current setup. They were paralyzed because they couldn't build enough certainty to act. They weren't missing your features. They were missing a number. That's the whole game. A buyer who can't quantify their problem has no internal pressure forcing a decision. The pain is vague, so the urgency is vague, so the deal slides to "next quarter" forever, the same drift that lets a "maybe" outlive every clean yes or no, which is why it pays to kill the maybe before it becomes a no-decision. You didn't lose to a cheaper vendor. You lost to a problem that was never made expensive enough to fix.
Section 3
Un-quantified, the buyer can only compare you on price
Put yourself in the buyer's chair for a second. You've told them their onboarding is "inefficient," their reporting is "a mess," their lead follow-up is "leaky." All true. All useless. None of those words have a dollar sign, so none of them create a budget. When the only number in the room is your price, the only conversation available is about your price. There's no counterweight. The buyer can't weigh "$18,000 to fix it" against anything, because the cost of not fixing it is a fog. So they do the rational thing: they treat your proposal as a discretionary expense and shop it. They compare your $18,000 to the next vendor's $14,000, because line by line, feature by feature, that's the only axis they've been handed. This is exactly the trap Closing Foundry describes when they define the cost of inaction, what the buyer keeps losing by not deciding. Their argument is sharp: reps who quantify the revenue, time, and risk the buyer is bleeding give that buyer a reason to act "that has nothing to do with the product" . The product is interchangeable. The bleed is not. When you only sell the product, you compete with every other product. When you quantify the bleed, you compete with the buyer's own inaction, and inaction has no salespeople defending it. It never gets on a comparison grid. It never lowers its price to win the deal. It just quietly keeps costing the buyer money while everyone debates your invoice. Mike Genstil of Pavilion, who built the VisualizeROI methodology, frames the mechanism plainly: "A quantified pain statement is the first step to uncovering real business impact and ROI, once a buyer sees they'll save a concrete number like $500/month, it dramatically changes their interest in understanding your solution" . Notice the sequence. The number comes first. Interest in your solution comes second, and only because the number created room for it. Most operators run this backwards. They lead with the solution and hope the buyer back-fills the value. The buyer almost never does, because that's your job, and you skipped it, the same discipline behind ROI you can defend instead of a number you hope survives scrutiny. There's a structural reason this matters more than ever. That same Challenger study found B2B buying groups now average upwards of 11 stakeholders . Your champion, the one person who actually took your call and felt the pain, has to walk into a room of ten other people and re-sell your solution without you present. What survives that retelling? Not your feature list. Not your case studies. Not how much you "got" their business. A number survives. "We're bleeding roughly $9,000 a month on this, and their fix costs $3,000 a month" travels through eleven people intact. "They seemed really sharp and I think it'd help a lot" dies in the hallway. Un-quantified, you're asking your champion to carry your whole pitch from memory. Quantified, you hand them a single sentence that does the arguing for them, the core of the champion's toolkit you leave behind.
Section 4
A worked example: the agency that kept losing on price
Let me make this concrete before I abstract it. Take a mid-size digital agency, call it the kind of 5-to-7-figure service business reading this, pitching a manufacturing client on a lead-response and CRM overhaul. Version one of the call: the agency walks through their process, their dashboard, their reporting cadence, their team's experience. The prospect nods. At the end, the agency quotes $6,000/month. The prospect says, "Let me take it to the team," and three weeks later comes back with "we're going to hold off" or "can you do $4,000?" Classic no-decision, or a price grind. The agency never gave the room of stakeholders anything but a price to react to. There was no problem on the table with a number on it, only a solution with a number on it, so the buyer did the only math available to them: they shopped the solution. Version two, same agency, same prospect, but they co-calculate the bleed. Instead of presenting, they ask: "Roughly how many inbound leads do you get a month?", Buyer: "About 200." "Honestly, what share get a follow-up within a day?", Buyer: "Maybe half. We're slow." "So call it 100 leads a month going cold. What's a closed deal worth to you, average?", Buyer: "Around $4,000 first year." "And your close rate on leads you actually work?", Buyer: "Maybe 10%." Now the agency doesn't tell the buyer anything. They just add it up out loud and let the buyer confirm: 100 neglected leads, 10% of which would've closed, is 10 lost deals a month at $4,000 each. That's $40,000 a month walking out the door, and the buyer said every number. The agency's $6,000/month isn't a cost anymore. It's 15% of the bleed. The proposal stops being "should we spend $6,000?" and becomes "should we keep losing $40,000 to save $6,000?" Same agency. Same price. Same solution. The only thing that changed is who did the arithmetic and when. That's the entire difference between competing on price and competing on math. And notice what the agency did not do: they did not argue, they did not defend a methodology, they did not run a feature demo. They asked four questions and added the answers together, the kind of restraint that comes from going one layer deeper instead of pitching. The buyer built the case against their own status quo, out loud, in their own words. You cannot negotiate someone out of a number they said themselves.
Section 5
The BGA framework: The Bleed Number
The Bleed Number is a discovery method, not a pitch. (Bleed Number: the recurring dollar amount a buyer's unsolved problem costs them every month, calculated live using only figures the buyer supplies.) You don't present ROI at the end, you co-author the cost of the problem in the middle, with the buyer holding the pen. Here's how to run it. (If you want the question scripts and the live-math checklist as something you can take into your next call, the LeadOS playbook is where this lives as a repeatable system, and the free template pack gives you the discovery-question scaffold to start with.) 1. Find the recurring loss event, not the annoyance. Before any math, isolate the specific repeating thing that costs money: leads going cold, hours re-keying data, customers churning, jobs quoted late. Rule of thumb: if it doesn't happen on a repeating cycle (weekly or monthly), it can't bleed, and you don't have a Bleed Number yet, keep digging. A one-off mistake is a story; a recurring loss is a budget. 2. Ask for the inputs; never supply them. Get volume, value, frequency, and failure rate from the buyer's own mouth: "How many a month? What's each one worth? How often does it go wrong?" Rule: every variable in the equation must be a number the buyer said out loud. The second you supply a figure, it becomes "your" number and it's arguable. Their numbers can't be argued with, they're the witness and the source. If they don't know a figure, that gap is useful too: it tells you they've never measured the thing that's hurting them. 3. Add it up out loud and make them confirm. Do the multiplication in the open: "So that's [volume] × [value] × [failure rate] = $X a month, does that feel right to you?" Metric: you want an explicit verbal "yes, that's about right." That confirmation is the asset. It converts a vague complaint into an agreed liability with a dollar sign, and it does it in front of you, so you can repeat it back later as their conclusion, not your claim. 4. Express it as a monthly bleed, not a one-time fix. Frame the loss with a ticking meter: "$X a month you're losing right now, and next month, and the month after." Rule: always per-month (or per-week), never lump-sum. A one-time number invites "we'll deal with it eventually." A recurring bleed makes every month of delay a visible, additive cost, inaction now has a price tag that grows while they "think about it." 5. Set your price as a fraction of their number. When you present, lead with their Bleed Number, then position your fee against it: "You're losing $40,000 a month. This is $6,000 a month to stop most of it." Rule of thumb: if your fee isn't visibly a fraction of the bleed, you either haven't found the real loss event (go back to step 1) or this genuinely isn't a problem worth your solution, and you've just saved yourself a no-decision death spiral and a client who'd have resented the invoice anyway. 6. Hand your champion the one-sentence version. Remember the room of 11-plus stakeholders . Before you leave, arm your champion: "When you take this to the team, the line is, we're bleeding $40K a month and the fix is $6K." Metric: if your champion can repeat the Bleed Number and your fee from memory, your deal can survive a room you'll never be in. If they can't, you haven't quantified hard enough, go back and make the number sharper and the sentence shorter. 7. Convert the bleed into the cost of waiting. Close the loop on indecision, the thing killing 56% of your winnable deals . Make delay itself the expensive choice: "Every month we wait is another $40,000. A 60-day decision cycle isn't free, it's $80,000." Rule: never let "let me think about it" sit there as the safe, cheap option. Quantified waiting is the JOLT play, you're not pressuring them toward you, you're showing them what standing still actually costs. The status quo stops looking like the careful choice and starts looking like the expensive one. The tagline holds the whole thing together: un-quantified, you sell a quote and compete on price. Quantified, you sell a Bleed Number and compete on math, and math always wins the room of eleven.
Section 6
You're running The Bleed Number right when…
You can finish this sentence before you ever send a proposal: "This buyer is losing roughly $____ per month, they said every figure in that equation themselves, and our fee is a visible fraction of it." If you can't fill that blank with the buyer's own numbers, you haven't done discovery, you've done a demo, and you're about to compete on price against a status quo that costs, as far as the buyer can tell, nothing. You're running it right when the proposal feels less like asking for money and more like presenting a receipt for stopping a bleed everyone in the room already agreed was real. And you'll know you have truly internalized it when you stop reaching for your price sheet at the start of a call and start reaching for it only after the buyer has, in their own words, told you what the problem is worth.